Skip to main content
Europlasma logo

Europlasma — Investor Relations & Filings

Ticker · ALEUP ISIN · FR001400CF13 LEI · 969500WYVNHBV1ABQ250 Euronext Growth Water supply; sewerage, waste management and remediation activities
Open in API
Filings indexed 506 across all filing types
Latest filing 2019-10-23 Regulatory Filings
Country FR France
Listing Euronext Growth ALEUP

About Europlasma

https://www.europlasma.com/en/

Europlasma is a company specializing in clean technology and energy solutions. Its core activities focus on the research, engineering, and application of plasma solutions for industrial purposes, particularly for the treatment of hazardous waste and gas. The company provides services for the destruction and valorization of asbestos waste. In the decarbonization sector, Europlasma transforms waste into Solid Recovered Fuel (SRF). Additionally, the company operates an industrial division that manufactures hollow bodies and anodized sheets for capacitors.

Recent filings

Filing Released Lang Actions
EUROPLASMA: Europlasma confirme le renouvellement de son éligibilité au dispositif PEA PME
Regulatory Filings Classification · 95% confidence The document is a press release dated October 23, 2019, titled "Europlasma confirme le renouvellement de son éligibilité au dispositif PEA PME" (Europlasma confirms the renewal of its eligibility for the PEA PME scheme). It discusses compliance with criteria related to employee count, revenue, and headquarters location based on 2018 consolidated accounts. This type of announcement, confirming eligibility for a specific financial/tax scheme or providing a general corporate update that doesn't fit core financial reports (10-K, IR, ER) or specific corporate actions (DIV, SHA, M&A), falls best under a general regulatory or corporate announcement category. Since it is not a standard financial report, a management discussion, or a specific insider trade/dividend notice, and it is a formal communication to the market, it is best classified as a Regulatory Filing (RNS) as a general announcement, or potentially Capital/Financing Update (CAP) due to the tax incentive context, but RNS is the broader fit for non-standard regulatory confirmations. Given the context of confirming eligibility for a tax-advantaged investment vehicle (PEA PME), it is a specific corporate status update. It is not a standard financial report, earnings release, or management discussion. RNS is the most appropriate fallback for specific, non-standard regulatory confirmations.
2019-10-23 French
EUROPLASMA: Résultats annuels 2018
Earnings Release Classification · 95% confidence The document is a press release titled 'Résultats annuels 2018' (Annual Results 2018) for Europlasma SA. It provides a summary of financial performance, including revenue, EBITDA, and operating results for the fiscal year ending December 31, 2018. While it contains financial data, it is structured as a press release (Communiqué de presse) rather than a full statutory Annual Report (10-K). According to the provided definitions, an 'Earnings Release' (ER) is the initial announcement of quarterly/periodical financial results containing key highlights. This document fits the ER category perfectly as it summarizes the annual financial highlights, operational activities, and management commentary. FY 2018
2019-10-21 French
EUROPLASMA: Drawdown ot the second tranche of 200 convertible bonds
Capital/Financing Update Classification · 99% confidence The document is explicitly titled as a "Press release (ABSTRACT)" dated October 18, 2019, announcing the "Drawdown of the second tranche of 200 convertible bonds." It details a financing transaction involving the issuance of OCABSAs (bonds convertible into new shares with warrants) to EHGOSF for €2,000,000. The content focuses entirely on the mechanics, purpose (financing working capital), and dilutive impact of this capital raising activity, including detailed tables showing the impact on equity per share and shareholder stakes. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-10-18 English
EUROPLASMA: Tirage de la deuxième tranche de 200 obligations convertibles en actions
Capital/Financing Update Classification · 99% confidence The document is a press release dated October 18, 2019, announcing the drawing (tirage) of the second tranche of convertible bonds with warrants attached (OCABSA) for a nominal amount of 2,000,000 euros. It details the impact on equity per share and shareholder participation, and provides a forward-looking schedule for future tranches. This announcement concerns a specific financing activity involving the issuance of securities (convertible bonds/warrants) to raise capital. This aligns directly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate financing event.
2019-10-18 French
EUROPLASMA: A framework partnership agreement with Orano Cycle has come into effect
M&A Activity Classification · 99% confidence The document is a press release dated September 17, 2019, announcing the signature of a 4-year renewable framework partnership agreement between Europlasma and Orano Cycle. This agreement covers industrial development and R&D related to hazardous and nuclear waste treatment. This type of announcement, detailing a significant business development or strategic agreement, does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, DIV, etc.). It is a general corporate announcement regarding a strategic transaction/collaboration. Since it is not a merger/takeover (TAR), a financing event (CAP), or a management change (MANG), the most appropriate general category for a significant, non-standard corporate announcement that doesn't fit elsewhere is the fallback category, Regulatory Filings (RNS), as it is a formal public disclosure. Given the short length (2243 chars) and the nature of announcing a new agreement, it is a specific corporate event disclosure, best classified as RNS if no other category applies.
2019-09-20 English
EUROPLASMA: Entrée en vigueur d'un accord-cadre de partenariat avec Orano Cycle
M&A Activity Classification · 99% confidence The document is a press release dated September 17, 2019, announcing a partnership agreement between Europlasma and Orano Cycle regarding the treatment of hazardous waste and toxic gases, including nuclear waste. This announcement details a strategic business development, including industrial and R&D components. This type of announcement, which is not a standard periodic financial report (like 10-K or IR), nor a management change (MANG), nor a financing event (CAP), nor a dividend notice (DIV), nor a specific regulatory filing like DIRS or MRQ, best fits the category for general corporate news or strategic updates that don't have a more specific code. Since it is a significant corporate announcement detailing a strategic agreement, and it is not a formal regulatory filing like an 8-K (which would map to RNS if no other category fits), it is most appropriately classified as a general Regulatory Filing (RNS) as a fallback for significant, non-standard corporate news, or potentially a Legal/Transaction related filing if the partnership implied a major transaction, but it reads more like a strategic alliance announcement. Given the options, RNS (Regulatory Filings / miscellaneous announcements) is the most suitable general category for a press release detailing a strategic partnership that doesn't fit the other specific financial or governance codes.
2019-09-17 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.